XML 24 R13.htm IDEA: XBRL DOCUMENT v3.25.1
Goodwill and Intangible Assets
3 Months Ended
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets

5. GOODWILL AND INTANGIBLE ASSETS

Goodwill

The following table presents the changes in the carrying value of goodwill by reportable segment for the three months ended March 31, 2025:

 

Cannabis - Canada

 

Balance as of December 31, 2024

$

42,315

 

Foreign currency translation adjustment

 

53

 

Balance as of March 31, 2025

$

42,368

 

Intangible Assets

Intangible assets consisted of the following as of:

Classification

 

March 31, 2025

 

 

December 31, 2024

 

Licenses

 

$

17,456

 

 

$

17,196

 

Brand and trademarks*

 

 

3,274

 

 

 

12,520

 

Customer relationships

 

 

12,546

 

 

 

12,530

 

Computer software

 

 

963

 

 

 

2,029

 

Other*

 

 

144

 

 

 

144

 

Less: Accumulated amortization

 

 

(9,909

)

 

 

(10,064

)

Less: Impairments*

 

 

 

 

 

(9,250

)

Intangibles, net

 

$

24,474

 

 

$

25,105

 

* Includes indefinite-lived intangible assets

The expected future amortization expense for definite-lived intangible assets as of March 31, 2025 was as follows:

Fiscal period

 

 

 

Remainder of 2025

 

$

2,250

 

2026

 

 

3,050

 

2027

 

 

3,050

 

2028

 

 

1,795

 

2029

 

 

1,794

 

Thereafter

 

 

9,117

 

Intangibles, net

 

$

21,056

 

Amortization expense for intangibles for the three months ended March 31, 2025 and 2024 were $794 and $830, respectively.

Assessment for Indicators of Impairment

At the end of each reporting period, the Company assesses whether events or changes in circumstances have occurred that would indicate an impairment. The Company considers external and internal factors, including overall financial performance and relevant entity-specific factors, as part of this assessment.

During the three months ended March 31, 2025 and 2024, the Company considered qualitative factors in assessing for impairment indicators for the Company’s U.S. and Canadian Cannabis segments.

At March 31, 2025 and 2024, the Company concluded that no impairment indicators existed as no events or circumstances occurred that would, more likely than not, reduce the fair value of the reporting units to be below their carrying amounts.